Robert P. Whalen, Commissioner of Health of New York v. Richard Roe, An Infant by Robert Roe, His Parent No. A-368, 423 U.S. 1313 (1975)
Robert P. Whalen, Commissioner of Health of New York v. Richard Roe, An Infant by Robert Roe, His Parent No. A-368, 423 U.S. 1313 (1975)
Robert P. Whalen, Commissioner of Health of New York v. Richard Roe, An Infant by Robert Roe, His Parent No. A-368, 423 U.S. 1313 (1975)
1313
96 S.Ct. 164
46 L.Ed.2d 18
The provisions at stake are those parts of 3331(6), 3332(2)(a), and 3334(4)
of the Law (Supp.1974) that require the name and address of each patient
receiving a Schedule II controlled substance to be reported to the applicant.
Schedule II drugs are those that have a high potential for abuse, but also have
an accepted medical use. They include opiates and amphetamines. Under the
Law, a doctor prescribing a Schedule II drug does so on a special serially
numbered triplicate prescription form. One copy is retained by the doctor, a
second goes to the pharmacist (if applicable), and the last copy goes to the
applicant, who transfers the data, including the name and address of the patient,
from the prescription to a centralized computer file.
Respondents brought this action shortly after the effective date of the
computerization program, alleging violations of their constitutional rights under
42 U.S.C. 1983 and grounding jurisdiction on 28 U.S.C. 1343(3).
Specifically, respondents claimed that mandatory disclosure of the name of a
patient receiving Schedule II drugs violated the patient's right of privacy and
interfered with the doctor's right to prescribe treatment for his patient solely on
the basis of medical considerations. A three-judge court was convened. Roe v.
Ingraham, 480 F.2d 102 (CA2 1973).
4
At trial, various respondents testified that they were inhibited from using or
prescribing Schedule II drugs they otherwise found beneficial because of a
reluctance to disclose their or their patients' identities to the State. While
questioning respondents' standing to sue, the applicant asserted that knowledge
of patients' names was necessary to enable the computer system to detect drug
abuse. When put to its proof by respondents, however, the applicant eventually
conceded that the names and addresses of patients were useful in detecting only
one abuse: patients who go from doctor to doctor (using the same name on each
visit) in order to obtain an excessive supply of drugs. Thereupon respondents
showed that in 15 months of operation the computer system had located only
one suspected "doctor-shopper" while processing over 125,000 prescriptions
per month. Thus respondents contended that the centralization of patients'
names and addresses served no compelling state interest sufficient to offset the
asserted invasion of privacy.
The three-judge court accepted respondents' arguments. The court read our
decisions in Roe v. Wade, 410 U.S. 113, 93 S.Ct. 705, 35 L.Ed.2d 147 (1973),
and Doe v. Bolton, 410 U.S. 179, 93 S.Ct. 739, 35 L.Ed.2d 201 (1973), as
placing the doctor-patient relationship among those zones of privacy accorded
constitutional protection. While noting that Roe and Doe concerned the most
intimate of personal relations, sexual intimacy and the decision to bear a child,
the court refused to hold the doctor-patient relationship constitutionally
protected only when matters of childbearing were at stake. Rather, it noted the
intimate nature of a patient's concern about his bodily ills and the medication
he takes, and held that these matters, too, are protected by the constitutional
right to privacy. While reaching this conclusion primarily on the basis of Roe
and Doe, the court drew some support from the concurring and dissenting
opinions in California Bankers Ass'n v. Shultz, 416 U.S. 21, 78, 94 S.Ct. 1494,
1525, 39 L.Ed.2d 812 (1974) (Powell, J., concurring); id., at 79, 94 S.Ct., at
1526 (Douglas, J., dissenting); id., at 91, 94 S.Ct., at 1532 (Brennan, J.,
dissenting); id., at 93, 94 S.Ct., at 1533 (Marshall, J., dissenting); 93, 94 S.Ct.
1494, 1525, 1526, 1532, 1533, 39 L.Ed.2d 812 (1974), which it read as
indicating that a majority of this Court would accord constitutional protection,
at least against a wholesale reporting requirement, to all "intimate areas of an
individual's personal affairs." Id., at 78, 94 S.Ct., at 1526 (Powell, J.,
concurring). Upon finding that respondents had a protected privacy interest in
the medication they received, the court balanced that interest against the State's
need for patients' names, and concluded that, with one suspect uncovered over
Finding those portions of the Law that demanded disclosure of patients' names
and addresses to the State to be unconstitutional on the facts, the court enjoined
the State from enforcing those provisions and from accepting for filing
prescriptions or other documents disclosing the identities of patients receiving
Schedule II drugs. The court also ordered the destruction of any name-bearing
prescription forms in the State's possession and the expungement of names from
all computer records. The court stayed the destruction and expungement order
pending disposition of the case by this Court; it refused, however, to stay its
declaration of unconstitutionality and its injunction against enforcement of the
provisions and acceptance of incoming prescriptions.
Thus the application for stay now before me concerns only those matters the
District Court refused to stay. The principles that govern a Circuit Justice's inchambers review of stay applications are well known. A single Justice will
grant a stay only in extraordinary circumstances. Certainly the judgment of the
lower court, which has considered the matter at length and close at hand, and
has found against the applicant both on the merits and on the need for a stay is
presumptively correct. To prevail here the applicant must meet a heavy burden
of showing not only that the judgment of the lower court was erroneous on the
merits, but also that the applicant will suffer irreparable injury if the judgment
is not stayed pending his appeal.
10
See also Aberdeen & Rockfish R. Co. v. SCRAP, 409 U.S. 1207, 1218, 93
S.Ct. 1, 7, 34 L.Ed.2d 21 (1972) (Burger, C. J., in chambers); Railway Express
Agency v. United States, 82 S.Ct. 466, 468, 7 L.Ed.2d 432, 434 (1962) (Harlan,
J., in chambers); United Fuel Gas Co. v. Public Service Comm'n, 278 U.S. 322,
326, 49 S.Ct. 157, 158, 73 L.Ed. 402 (1929).
12
Applying these standards to the application before me, I conclude a stay should
not be granted. The three-judge court gave careful consideration to applicant's
motion for a stay and, indeed, granted one insofar as it deemed necessary to
prevent irreparable harm to applicant's interests. Applicant has shown nothing
to persuade me the lower court erred. If applicant's position is sustained on
appeal, all the data it is precluded from processing by the District Court's order
will be readily available from the State's doctors and pharmacists, who are
required by law to retain the complete prescription form for five years. The
information now denied the State's computers can thus be located and tabulated
at a later date. While the State may suffer delay in the complete implementation
of its computerization program, delay alone is not, on these facts, irreparable
injury.
13
14